Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRTX NYSE:CO NASDAQ:MRAI NASDAQ:VMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXBiorestorative Therapies$1.51-1.9%$1.57$1.21▼$2.55$12.29M-0.4398,429 shs49,802 shsCOGlobal Cord Blood$1.00+11.1%$0.95$2.03▼$5.50$121.55M0.16216,519 shs3,587 shsMRAIMarpai$1.21-1.6%$1.35$0.43▼$1.68$20.90M4.6616,796 shs13,181 shsVMDViemed Healthcare$6.76-0.3%$6.77$5.93▼$9.81$262.97M1.38218,385 shs147,858 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXBiorestorative Therapies-1.95%-6.21%-0.66%-12.21%-10.65%COGlobal Cord Blood0.00%-4.76%+81.82%-4.76%-33.33%MRAIMarpai-1.63%-5.47%-15.97%-6.92%+137.25%VMDViemed Healthcare-0.29%-1.60%-1.89%+2.42%-10.94%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXBiorestorative Therapies$1.51-1.9%$1.57$1.21▼$2.55$12.29M-0.4398,429 shs49,802 shsCOGlobal Cord Blood$1.00+11.1%$0.95$2.03▼$5.50$121.55M0.16216,519 shs3,587 shsMRAIMarpai$1.21-1.6%$1.35$0.43▼$1.68$20.90M4.6616,796 shs13,181 shsVMDViemed Healthcare$6.76-0.3%$6.77$5.93▼$9.81$262.97M1.38218,385 shs147,858 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXBiorestorative Therapies-1.95%-6.21%-0.66%-12.21%-10.65%COGlobal Cord Blood0.00%-4.76%+81.82%-4.76%-33.33%MRAIMarpai-1.63%-5.47%-15.97%-6.92%+137.25%VMDViemed Healthcare-0.29%-1.60%-1.89%+2.42%-10.94%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRTXBiorestorative Therapies 0.00N/AN/AN/ACOGlobal Cord Blood 0.00N/AN/AN/AMRAIMarpai 0.00N/AN/AN/AVMDViemed Healthcare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRTXBiorestorative Therapies$605.20K19.91N/AN/A$1.23 per share1.23COGlobal Cord Blood$1.24B0.10$0.24 per share4.19$6.34 per share0.16MRAIMarpai$34.87M0.60N/AN/A($1.72) per share-0.70VMDViemed Healthcare$224.26M1.17$0.94 per share7.21$3.41 per share1.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRTXBiorestorative Therapies-$8.98M-$1.27N/AN/AN/A-1,772.40%-137.00%-88.31%11/11/2025 (Estimated)COGlobal Cord Blood$79.04M$0.641.56∞N/AN/AN/AN/AN/AMRAIMarpai-$28.75M-$0.87N/A∞N/A-85.70%N/A-100.23%11/11/2025 (Estimated)VMDViemed Healthcare$11.27M$0.3419.88∞N/A5.80%10.38%7.88%11/5/2025 (Estimated)Latest CO, VMD, MRAI, and BRTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025BRTXBiorestorative Therapies-$0.41-$0.30+$0.11-$0.30$0.34 million$0.30 million8/6/2025Q2 2025VMDViemed Healthcare$0.0850$0.08-$0.0050$0.08$63.50 million$63.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRTXBiorestorative TherapiesN/AN/AN/AN/AN/ACOGlobal Cord Blood$0.088.00%N/A12.50%N/AMRAIMarpaiN/AN/AN/AN/AN/AVMDViemed HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRTXBiorestorative TherapiesN/A2.072.07COGlobal Cord BloodN/AN/AN/AMRAIMarpaiN/A0.820.82VMDViemed Healthcare0.021.481.37Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRTXBiorestorative Therapies69.38%COGlobal Cord BloodN/AMRAIMarpai49.75%VMDViemed Healthcare74.24%Insider OwnershipCompanyInsider OwnershipBRTXBiorestorative Therapies30.80%COGlobal Cord Blood0.50%MRAIMarpai46.10%VMDViemed Healthcare20.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRTXBiorestorative Therapies77.98 million5.52 millionNot OptionableCOGlobal Cord Blood1,202121.55 millionN/ANo DataMRAIMarpai15017.27 million5.61 millionNo DataVMDViemed Healthcare1,17938.79 million31.03 millionNot OptionableCO, VMD, MRAI, and BRTX HeadlinesRecent News About These CompaniesPunch & Associates Investment Management Inc. Sells 265,651 Shares of Viemed Healthcare, Inc. $VMDSeptember 9, 2025 | marketbeat.comTrexquant Investment LP Has $717,000 Stock Holdings in Viemed Healthcare, Inc. $VMDSeptember 9, 2025 | marketbeat.comNuveen LLC Acquires New Position in Viemed Healthcare, Inc. $VMDSeptember 4, 2025 | marketbeat.comParadigm Capital Management Inc. NY Sells 100,000 Shares of Viemed Healthcare, Inc. $VMDSeptember 2, 2025 | marketbeat.comGabelli Funds LLC Acquires 45,837 Shares of Viemed Healthcare, Inc. $VMDSeptember 2, 2025 | marketbeat.comJerome Cambre Sells 4,880 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) StockAugust 16, 2025 | marketbeat.comMichael Moore Sells 50,090 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) StockAugust 14, 2025 | insidertrades.comViemed Healthcare, Inc. (NASDAQ:VMD) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comViemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comViemed VMD Q2 2025 Earnings Call TranscriptAugust 7, 2025 | fool.comViemed (VMD) Q2 Revenue Rises 15%August 6, 2025 | fool.comViemed Healthcare Achieves Record Q2 2025 Revenues and Expands GuidanceAugust 6, 2025 | msn.comViemed Healthcare, Inc.: Viemed Healthcare Announces Second Quarter 2025 Financial ResultsAugust 6, 2025 | finanznachrichten.deViemed Healthcare Announces Second Quarter 2025 Financial ResultsAugust 6, 2025 | accessnewswire.comAViemed Healthcare Announces Second Quarter 2025 Earnings Conference Call DetailsJuly 22, 2025 | accessnewswire.comALafayette’s Viemed completes $26 million acquisition of Illinois medical equipment firmJuly 9, 2025 | theadvertiser.comTViemed officially adds Lehan’s to familyJuly 7, 2025 | hmenews.comHViemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial ResultsJuly 2, 2025 | accessnewswire.comAInsider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares of StockJuly 1, 2025 | insidertrades.comViemed Healthcare: Getting More AirJune 25, 2025 | seekingalpha.comviemed healthcare shareholders approve key amendments and director electionsJune 7, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesNIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025The Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 20252 Data Center REITs That Look Good in Any PortfolioBy Sam Quirke | September 8, 2025Next-Gen Defense: 3 Stocks Riding the New Global Arms RaceBy Nathan Reiff | August 18, 2025CO, VMD, MRAI, and BRTX Company DescriptionsBiorestorative Therapies NASDAQ:BRTX$1.51 -0.03 (-1.95%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$1.52 +0.01 (+0.66%) As of 09/15/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Global Cord Blood NYSE:CO$1.00 +0.10 (+11.11%) As of 09/12/2025Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.Marpai NASDAQ:MRAI$1.21 -0.02 (-1.63%) As of 09/15/2025 03:59 PM EasternMarpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.Viemed Healthcare NASDAQ:VMD$6.76 -0.02 (-0.29%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$6.88 +0.12 (+1.83%) As of 09/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Reddit Hits Record Highs: Why Wall Street Is Taking Notice Royal Caribbean's 33% Dividend Hike Signals Deeper Growth FuelCell Energy's Stock: Is a Fundamental Breakout Underway? After a Strong Wall Street Debut, Klarna's Real Work Begins MarketBeat Week in Review – 09/08 - 09/12 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
